Literature DB >> 34064024

Role of the Endocannabinoid System in the Adipose Tissue with Focus on Energy Metabolism.

Volatiana Rakotoarivelo1,2, Jyoti Sihag1,2,3,4, Nicolas Flamand1,2.   

Abstract

The endocannabinoid system is involved in a wide range of processes including the control of energy acquisition and expenditure. Endocannabinoids and their receptors are present in the central nervous system but also in peripheral tissues, notably the adipose tissues. The endocannabinoid system interacts with two main hormones regulating appetite, namely leptin and ghrelin. The inhibitory effect of the cannabinoid receptor 1 (CB1) antagonist rimonabant on fat mass suggested that the endocannabinoid system can also have a peripheral action in addition to its effect on appetite reduction. Thus, several investigations have focused on the peripheral role of the endocannabinoid system in the regulation of metabolism. The white adipose tissue stores energy as triglycerides while the brown adipose tissue helps to dissipate energy as heat. The endocannabinoid system regulates several functions of the adipose tissues to favor energy accumulation. In this review we will describe the presence of the endocannabinoid system in the adipose tissue. We will survey the role of the endocannabinoid system in the regulation of white and brown adipose tissue metabolism and how the eCB system participates in obesity and metabolic diseases.

Entities:  

Keywords:  2-arachidonoyl-glycerol (2-AG); N-arachidonoyl-ethanolamine (AEA); brown adipose tissue; endocannabinoid; energy metabolism; white adipose tissue

Year:  2021        PMID: 34064024     DOI: 10.3390/cells10061279

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  289 in total

Review 1.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

2.  Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.

Authors:  Claudia Manca; Besma Boubertakh; Nadine Leblanc; Thomas Deschênes; Sebastien Lacroix; Cyril Martin; Alain Houde; Alain Veilleux; Nicolas Flamand; Giulio G Muccioli; Frédéric Raymond; Patrice D Cani; Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  J Lipid Res       Date:  2019-11-05       Impact factor: 5.922

3.  Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain.

Authors:  John C Ashton; Rosanna M A Rahman; Shiva M Nair; Brad A Sutherland; Michelle Glass; Ian Appleton
Journal:  Neurosci Lett       Date:  2006-11-22       Impact factor: 3.046

4.  The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.

Authors:  B Poirier; J-P Bidouard; C Cadrouvele; X Marniquet; B Staels; S E O'Connor; P Janiak; J-M Herbert
Journal:  Diabetes Obes Metab       Date:  2005-01       Impact factor: 6.577

Review 5.  The evolution and comparative neurobiology of endocannabinoid signalling.

Authors:  Maurice R Elphick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

6.  The CB1 endocannabinoid system modulates adipocyte insulin sensitivity.

Authors:  Roja Motaghedi; Timothy E McGraw
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

7.  Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.

Authors:  Shinya U Amano; Jessica L Cohen; Pranitha Vangala; Michaela Tencerova; Sarah M Nicoloro; Joseph C Yawe; Yuefei Shen; Michael P Czech; Myriam Aouadi
Journal:  Cell Metab       Date:  2013-12-26       Impact factor: 27.287

8.  AMP-activated protein kinase plays a role in the control of food intake.

Authors:  Ulrika Andersson; Karin Filipsson; Caroline R Abbott; Angela Woods; Kirsty Smith; Stephen R Bloom; David Carling; Caroline J Small
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

9.  Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.

Authors:  Giuseppe D'Argenio; Stefania Petrosino; Carmen Gianfrani; Marta Valenti; Giuseppe Scaglione; Ilenia Grandone; Santosh Nigam; Italo Sorrentini; Giuseppe Mazzarella; Vincenzo Di Marzo
Journal:  J Mol Med (Berl)       Date:  2007-03-30       Impact factor: 5.606

Review 10.  An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity.

Authors:  Artemis P Simopoulos
Journal:  Nutrients       Date:  2016-03-02       Impact factor: 5.717

View more
  6 in total

Review 1.  (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders.

Authors:  Jyoti Sihag; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2022-01-14       Impact factor: 3.876

2.  The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids.

Authors:  Amrita Vijay; Afroditi Kouraki; Sameer Gohir; James Turnbull; Anthony Kelly; Vicky Chapman; David A Barrett; William J Bulsiewicz; Ana M Valdes
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study.

Authors:  Madis Parksepp; Liina Haring; Kalle Kilk; Kadri Koch; Kärt Uppin; Raul Kangro; Mihkel Zilmer; Eero Vasar
Journal:  Biomedicines       Date:  2022-01-24

Review 4.  Cannabinoids and Chronic Liver Diseases.

Authors:  Ralph-Sydney Mboumba Bouassa; Giada Sebastiani; Vincenzo Di Marzo; Mohammad-Ali Jenabian; Cecilia T Costiniuk
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

5.  N-linoleyltyrosine ameliorates high-fat diet-induced obesity in C57BL/6 mice via cannabinoid receptor regulation.

Authors:  Zheng-Yu Yang; Yi-Ying Wu; Yi Zhou; Yun-Qi Yang; Jia-Hui Zhang; Tao He; Sha Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-30       Impact factor: 6.055

6.  Expression of Functional Cannabinoid Type-1 (CB1) Receptor in Mitochondria of White Adipocytes.

Authors:  Antonio C Pagano Zottola; Ilenia Severi; Astrid Cannich; Philippe Ciofi; Daniela Cota; Giovanni Marsicano; Antonio Giordano; Luigi Bellocchio
Journal:  Cells       Date:  2022-08-19       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.